ReviewZeitschrift fur Rheumatologie2026
[Large language models in rheumatology : New ways of knowledge transfer].
Review in Zeitschrift fur Rheumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Structured prompting as reusable clinical tools.EULAR rheumatology open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medical knowledge is growing exponentially in rheumatology, posing increasing challenges for knowledge dissemination among physicians, educators and patients. Traditional information and learning formats are reaching their limits in view of the rapid emergence of new clinical studies, guidelines and treatment concepts. Large language models (LLMs) offer the possibility to structure, synthesize and contextually adapt extensive and complex information within a short time. This opens new perspectives for clinical decision support, medical education, patient education and scientific work in rheumatology. This article systematically categorizes the use of LLMs across these fields of application and discusses the opportunities, risks and practical implications using selected examples that colleagues can immediately apply. Early data suggest a high potential for use and growing acceptance among physicians, students and patients; however, significant challenges remain. These include concerns regarding the validity and transparency of the generated content, potential biases, data protection issues and the risk of uncritical adoption of artificial intelligence (AI)-generated recommendations. The use of LLMs can make rheumatological knowledge rapidly, individually, and easily accessible but does not replace medical responsibility or clinical expertise. An evidence-based evaluation, clear regulatory framework conditions, safe integration into existing workflows and targeted training and governance concepts are essential to harness the potential of LLMs for knowledge dissemination in rheumatology in a sustainable and responsible manner.
Indexed as
Identifiers
41860629What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.